Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825.
Abruzzese
Elisabetta
E
Del Poeta
Giovanni
G
Barbato
Rosanna
R
Fratoni
Stefano
S
Trawinska
Malgorzata M
MM
Zangrilli
Daniela
D
Coletta
Angela M
AM
Patroi
Ivona M
IM
Francesconi
Francesca
F
Santeusanio
Giuseppe
G
De Fabritiis
Paolo
P
Amadori
Sergio
S
D000368:Aged; D000069439:Dasatinib; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013844:Thiazoles / Q000627:therapeutic use*
D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib